A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment failures and improving quality of life. This breakthrough marks a significant advancement after 50 years of stagnant treatment options.

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid tablets.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have shown that a drug called benralizumab is effective at treating acute attacks of both asthma and chronic obstructive pulmonary disease (COPD),

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.